105.45MMarket Cap-10238P/E (TTM)
2.260High2.150Low26.28KVolume2.270Open2.300Pre Close58.30KTurnover0.06%Turnover RatioLossP/E (Static)49.05MShares2.55052wk High1.91P/B90.47MFloat Cap1.12052wk Low--Dividend TTM42.08MShs Float16.120Historical High--Div YieldTTM4.78%Amplitude1.120Historical Low2.218Avg Price1Lot Size
MediciNova Stock Forum
📊⚡️📊
MediciNova Inc - Patent Is Expected to Expire No Earlier Than May 26, 2042
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver
MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis
MediciNova (NASDAQ: MNOV) announced it will receive monetary damages following the settlement of Sanofi-Novartis litigation. The company plans to use this non-dilutive fundingto support ongoing clinical development programs, particularly focusing on their late-stage pipeline targeting inflammatory, metabolic, and neurodegenerative diseases. The settlement validates MediciNova's in...
Medicinova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis
No comment yet